Related Experiment Videos
Regional flow adjusted hemoperfusion during coronary angioplasty: circulatory support/myocardial protection
1Methodist Heart Center, Methodist Hospital, Lubbock, Texas, USA.
Insights
Routine angioplasty is effective for stable patients. Active hemoperfusion offers myocardial protection and hemodynamic support, proving reliable and cost-effective for coronary interventions.
Area of Science:
- Cardiovascular Interventions
- Medical Device Technology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a standard procedure for stable patients.
- Hemodynamic instability presents challenges during coronary interventions.
Purpose of the Study:
- To evaluate the efficacy and advantages of active hemoperfusion during coronary angioplasty.
- To compare active hemoperfusion devices with existing circulatory support systems.
Main Methods:
- Utilized routine angioplasty equipment in conjunction with active hemoperfusion.
- Assessed a flow-adjustable active antegrade hemoperfusion pump.
- Compared the device with cardiopulmonary support (CPS) systems.
Main Results:
- Routine PTCA catheters show high success rates in stable patients.
- Active hemoperfusion provides myocardial protection and aids hemodynamically unstable patients.
- The evaluated hemoperfusion pump is reliable, user-friendly, and cost-effective, with minimal instrumentation requirements compared to bulky CPS.
Conclusions:
- Active hemoperfusion is advantageous for patients with hemodynamic instability during coronary interventions.
- This hemoperfusion pump offers a simpler, more cost-effective alternative to traditional CPS systems.
Abstract:
Routine percutaneous transluminal coronary angioplasty catheters are adequate and demonstrate high success rates in balloon angioplasty with stable patients. Active hemoperfusion seems to offer an advantage in patients with hemodynamic instability. Active hemoperfusion provides myocardial protection during coronary interventions and can be applied in conjunction with routine angioplasty equipment. When compared with other devices demonstrating clinical utility in a supported angioplasty setting, this flow adjustable active antegrade hemoperfusion pump appears reliable, simple to use, cost-effective, and requires much less instrumentation than the more bulky CPS systems.